Wanner C - Search Results

1

Uremia-specific alterations in lipid metabolism.

Wanner C, Krane V. Wanner C, et al. Blood Purif. 2002;20(5):451-3. doi: 10.1159/000063557. Blood Purif. 2002. PMID: 12207090 Review.

2

Abnormalities in uremic lipoprotein metabolism and its impact on cardiovascular disease.

Quaschning T, Krane V, Metzger T, Wanner C. Quaschning T, et al. Among authors: wanner c. Am J Kidney Dis. 2001 Oct;38(4 Suppl 1):S14-9. doi: 10.1053/ajkd.2001.27384. Am J Kidney Dis. 2001. PMID: 11576915 Review.

3

Lipid changes and statins in chronic renal insufficiency and dialysis.

Wanner C, Krane V, Metzger T, Quaschning T. Wanner C, et al. J Nephrol. 2001 Nov-Dec;14 Suppl 4:S76-80. J Nephrol. 2001. PMID: 11798151 Review.

4

Rationale and design of a trial improving outcome of type 2 diabetics on hemodialysis. Die Deutsche Diabetes Dialyse Studie Investigators.

Wanner C, Krane V, Ruf G, März W, Ritz E. Wanner C, et al. Kidney Int Suppl. 1999 Jul;71:S222-6. doi: 10.1046/j.1523-1755.1999.07158.x. Kidney Int Suppl. 1999. PMID: 10412782

5

[Treatment of dyslipoproteinemia in chronic renal failure].

Krane V, Wanner C. Krane V, et al. Among authors: wanner c. MMW Fortschr Med. 2006 Apr 6;148(14):34-7. MMW Fortschr Med. 2006. PMID: 16669278 German.

6

Dyslipidaemia in chronic kidney disease.

Krane V, Wanner C. Krane V, et al. Among authors: wanner c. Minerva Urol Nefrol. 2007 Sep;59(3):299-316. Minerva Urol Nefrol. 2007. PMID: 17912226 Review.

7

Lipid lowering in end-stage renal disease.

Wanner C, Metzger T, Krane V. Wanner C, et al. Saudi J Kidney Dis Transpl. 2001 Jan-Mar;12(1):3-8. Saudi J Kidney Dis Transpl. 2001. PMID: 18209353 No abstract available.

8

Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation.

Storey BC, Staplin N, Haynes R, Reith C, Emberson J, Herrington WG, Wheeler DC, Walker R, Fellström B, Wanner C, Landray MJ, Baigent C; SHARP Collaborative Group. Storey BC, et al. Among authors: wanner c. Kidney Int. 2018 Apr;93(4):1000-1007. doi: 10.1016/j.kint.2017.09.011. Epub 2017 Nov 14. Kidney Int. 2018. PMID: 29146277 Free PMC article.

9

[Phenotyping of type 2 diabetes mellitus by "genetic field work": are data sufficient that are based only on a questionnaire?].

Mönks D, Swoboda F, Breunig F, Krane V, Drechsler C, Blum H, Leising D, Wanner C. Mönks D, et al. Among authors: wanner c. Dtsch Med Wochenschr. 2007 Sep;132(37):1875-9. doi: 10.1055/s-2007-984978. Dtsch Med Wochenschr. 2007. PMID: 17823877 German.

10

The effect of spironolactone on diastolic function in haemodialysis patients.

Hauser T, Dornberger V, Malzahn U, Grebe SJ, Liu D, Störk S, Nauck M, Friedrich N, Dörr M, Wanner C, Krane V, Hammer F; MiREnDa Study Group; Collaborating investigators (sites). Hauser T, et al. Among authors: wanner c. Int J Cardiovasc Imaging. 2021 Jun;37(6):1927-1936. doi: 10.1007/s10554-021-02176-5. Epub 2021 Feb 5. Int J Cardiovasc Imaging. 2021. PMID: 33544240 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,041 results

Search Page

Filters